175 related articles for article (PubMed ID: 31743129)
1. Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients.
Fuchs TL; Sioson L; Sheen A; Jafari-Nejad K; Renaud CJ; Andrici J; Ahadi M; Chou A; Gill AJ
Am J Surg Pathol; 2020 Apr; 44(4):536-544. PubMed ID: 31743129
[TBL] [Abstract][Full Text] [Related]
2. Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases.
Fuchs TL; Pearson A; Pickett J; Diakos C; Dewar R; Chan D; Guminski A; Menzies A; Baron-Hay S; Sheen A; Sioson L; Chou A; Gill AJ
Pathology; 2020 Aug; 52(5):515-521. PubMed ID: 32553444
[TBL] [Abstract][Full Text] [Related]
3. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
[TBL] [Abstract][Full Text] [Related]
5. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
7. Stromal tumour-infiltrating lymphocytes (TILs) assessed using the ITWG system do not predict overall survival in a cohort of 337 cases of mesothelioma.
Fuchs TL; Chou A; Sioson L; Sheen A; Gill AJ
Histopathology; 2020 Jun; 76(7):1095-1101. PubMed ID: 32215942
[No Abstract] [Full Text] [Related]
8. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
[TBL] [Abstract][Full Text] [Related]
11. Tumor Microenvironmental Prognostic Risk in Primary Operable Small Intestinal Adenocarcinoma.
Jun SY; Lee EJ; Hong SM; Jung ES; Chung JY
Am J Surg Pathol; 2021 Jul; 45(7):917-929. PubMed ID: 33443865
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer.
Rakaee M; Kilvaer TK; Dalen SM; Richardsen E; Paulsen EE; Hald SM; Al-Saad S; Andersen S; Donnem T; Bremnes RM; Busund LT
Hum Pathol; 2018 Sep; 79():188-198. PubMed ID: 29885403
[TBL] [Abstract][Full Text] [Related]
13. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
[TBL] [Abstract][Full Text] [Related]
15. Combinatory statuses of tumor stromal percentage and tumor infiltrating lymphocytes as prognostic factors in stage III colorectal cancers.
Jin HY; Yoo SY; Lee JA; Wen X; Kim Y; Park HE; Kwak Y; Cho NY; Bae JM; Kim JH; Lee HS; Kang GH
J Gastroenterol Hepatol; 2022 Mar; 37(3):551-557. PubMed ID: 35018665
[TBL] [Abstract][Full Text] [Related]
16. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
